PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.82%
Revenue growth above 1.5x SEDG's 4.85%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-14.41%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
154.68%
Positive EBIT growth while SEDG is negative. John Neff might see a substantial edge in operational management.
-285.20%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
123.94%
Positive net income growth while SEDG is negative. John Neff might see a big relative performance advantage.
124.49%
Positive EPS growth while SEDG is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
124.49%
Positive diluted EPS growth while SEDG is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.08%
Share reduction more than 1.5x SEDG's 0.29%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.69%
Diluted share count expanding well above SEDG's 0.15%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
89.83%
OCF growth above 1.5x SEDG's 44.98%. David Dodd would confirm a clear edge in underlying cash generation.
53.97%
FCF growth above 1.5x SEDG's 4.69%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-61.45%
Negative 10Y revenue/share CAGR while SEDG stands at 6.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-69.98%
Negative 5Y CAGR while SEDG stands at 299.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.34%
Negative 3Y CAGR while SEDG stands at 84.18%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-101.02%
Negative 10Y OCF/share CAGR while SEDG stands at 214.20%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.40%
Negative 5Y OCF/share CAGR while SEDG is at 192.55%. Joel Greenblatt would question the firm’s operational model or cost structure.
92.53%
3Y OCF/share CAGR 1.25-1.5x SEDG's 68.15%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
113.73%
Net income/share CAGR at 75-90% of SEDG's 128.01%. Bill Ackman would press for strategic moves to boost long-term earnings.
105.87%
Below 50% of SEDG's 238.72%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
110.42%
3Y net income/share CAGR 50-75% of SEDG's 178.57%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
-82.79%
Negative equity/share CAGR over 10 years while SEDG stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-69.16%
Negative 5Y equity/share growth while SEDG is at 266.38%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
251.81%
3Y equity/share CAGR above 1.5x SEDG's 104.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-29.28%
Firm’s AR is declining while SEDG shows 41.94%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-11.18%
Inventory is declining while SEDG stands at 24.75%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.82%
Similar asset growth to SEDG's 9.19%. Walter Schloss finds parallel expansions or investment rates.
6.19%
1.25-1.5x SEDG's 5.17%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
1.24%
Debt shrinking faster vs. SEDG's 5.29%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
46.53%
R&D growth drastically higher vs. SEDG's 15.56%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
49.72%
SG&A growth well above SEDG's 9.20%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.